Carine Chaleteix - Publications

Measurable Residual Disease-Guided Therapy in Newly Diagnosed Myeloma.

Journal: The New England journal of medicine

Published: June 03, 2025

High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing.

Journal: Blood

Published: May 15, 2025

Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: November 21, 2023

Pomalidomide and dexamethasone until progression after first salvage therapy in multiple myeloma.

Journal: British journal of haematology

Published: November 20, 2022

Relation between auditory difficulties and bortezomib-induced peripheral neuropathy in multiple myeloma: a single-center cross-sectional study.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: November 09, 2021

Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.

Journal: Blood

Published: November 01, 2021

Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study.

Journal: Frontiers in pharmacology

Published: December 03, 2020

Cerebral aspergillosis in a patient on ibrutinib therapy.

Journal: British journal of haematology

Published: December 01, 2020

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma.

Journal: Blood

Published: July 14, 2018

Chemotherapy-induced peripheral neuropathy: Symptomatology and epidemiology

Journal: Bulletin du cancer

Published: September 25, 2017

Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 08, 2017

Pomalidomide for multiple myeloma

Journal: Bulletin du cancer

Published: December 19, 2016